PETRACCA, GRAZIANA
 Distribuzione geografica
Continente #
NA - Nord America 238
EU - Europa 149
AS - Asia 89
SA - Sud America 3
AF - Africa 2
Totale 481
Nazione #
US - Stati Uniti d'America 233
CN - Cina 44
SG - Singapore 34
IE - Irlanda 27
SE - Svezia 27
RU - Federazione Russa 24
FR - Francia 23
IT - Italia 18
DE - Germania 12
KR - Corea 10
FI - Finlandia 7
GB - Regno Unito 7
CA - Canada 3
CO - Colombia 3
ES - Italia 2
MX - Messico 2
TG - Togo 2
BE - Belgio 1
LV - Lettonia 1
TW - Taiwan 1
Totale 481
Città #
Chandler 74
Ashburn 32
Singapore 29
Dublin 25
Beijing 10
Seoul 10
Orlando 9
Kent 8
Lawrence 8
New York 8
Princeton 8
Redmond 8
Verona 8
Washington 7
Wilmington 7
Helsinki 5
Sindelfingen 5
Dallas 4
Bogotá 3
Seattle 3
Southend 3
Stoney Creek 3
Dongguan 2
Haikou 2
Jacksonville 2
Lanzhou 2
Lappeenranta 2
Lomé 2
London 2
Milan 2
Munich 2
Santa Clara 2
Zaragoza 2
Ann Arbor 1
Brussels 1
Cambridge 1
Changsha 1
Chicago 1
Esslingen am Neckar 1
Falkenstein 1
Frankfurt am Main 1
Guangzhou 1
Jianning 1
Mehlingen 1
New Taipei City 1
Norwalk 1
Oxford 1
Shenyang 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Tianjin 1
Xi'an 1
Totale 319
Nome #
GLP-1 receptor agonists for NAFLD treatment in patients with and without type 2 diabetes: an updated meta-analysis. 63
Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials 59
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis 59
Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure 53
Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes 50
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis 49
Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials 47
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies 43
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals 40
Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals 31
Totale 494
Categoria #
all - tutte 2.702
article - articoli 2.702
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 5 1 0 2 5 0 2 1 0
2021/202247 2 6 0 7 0 5 1 2 5 4 5 10
2022/2023200 9 21 21 33 15 47 6 11 26 0 8 3
2023/2024139 7 3 13 14 15 33 6 13 0 11 22 2
2024/202592 9 14 5 54 8 2 0 0 0 0 0 0
Totale 494